Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on fenfluramine in Lennox-Gastaut epilepsy
2015-004008-46Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fenfluramine in Lennox-Gastaut syndrome (LGS), sponsored by UZ Leuven. Primary endpoint: Responder and seizure-free rates across major seizure types. Started Nov 2015; status: completed.
02
Drugs
fenfluramine
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on 2015-004008-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004008-46.